| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/05/2006 | EP1453777B1 Functionalized higher diamondoids |
| 04/05/2006 | EP1450822A4 Polymeric thiol-linked prodrugs |
| 04/05/2006 | EP1438104B1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 04/05/2006 | EP1435235B1 Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 04/05/2006 | EP1383522B1 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 04/05/2006 | EP1370544B1 Nitric oxide donors based on metallic centres |
| 04/05/2006 | EP1351969A4 Method for generating immortal dendritic cell lines |
| 04/05/2006 | EP1331005B1 Medicinal compositions for concominant use as anticancer atent |
| 04/05/2006 | EP1307197B1 Compositions for the treatment of cancer comprising a topoisomerase inhibitor and thalidomide |
| 04/05/2006 | EP1300398B1 Propane-1,3-dione derivatives |
| 04/05/2006 | EP1286671B1 Compositions for the treatment of colorectal cancer comprising thalidomide and irinotecan |
| 04/05/2006 | EP1280524B1 Methods and compositions for modulating alpha adrenergic receptor activity |
| 04/05/2006 | EP1244668B1 Purine derivatives, process for their preparation and use thereof |
| 04/05/2006 | EP1173427B1 Hydroxamic acid derivative |
| 04/05/2006 | EP1147413B1 Growth differentiation factor inhibitors and uses therefor |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | EP1086098B1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/05/2006 | EP1049718B1 Use of the antibody 271.14d9.f8 (dsm acc2331) to inhibit in vitro alphavbeta6-integrin attachment to fibronectin |
| 04/05/2006 | EP0963207B1 IL12 for the gene therapy of tumours |
| 04/05/2006 | EP0941364B1 Process aimed at evidencing the state of a malignant cell and process for treatment |
| 04/05/2006 | EP0871673B1 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety |
| 04/05/2006 | EP0729507B1 Composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor |
| 04/05/2006 | CN1756842A Branched neutral amino acid transporters acting as single molecule |
| 04/05/2006 | CN1756768A Trimeric polypeptide construct to induce an enduring t cell response |
| 04/05/2006 | CN1756765A Metastin derivatives and their use |
| 04/05/2006 | CN1756763A Dimerized peptide |
| 04/05/2006 | CN1756758A Novel cantharidimide and norcantharidimide derivant and its application in medicine |
| 04/05/2006 | CN1756563A Use of myxoma virus for therapeutic treatment of cancer and chronic viral infection |
| 04/05/2006 | CN1756555A Medicament |
| 04/05/2006 | CN1756549A Antineoplastic combinations comprising a rapamycin dderiovative and an aromatse inhibitor |
| 04/05/2006 | CN1756543A Inhibitor for liver cancer onset and progress |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1754576A Tumour cell vaccine preparation method |
| 04/05/2006 | CN1754574A Use of immune cell for treating blood coloboma symptom and arrest of bone marrow |
| 04/05/2006 | CN1754569A Use of polyproline polypeptide in preparing medicine for treating malignant tumour |
| 04/05/2006 | CN1754565A Green dendrobium stem compostition and its preparation method |
| 04/05/2006 | CN1754564A Green dendrobium stem pharmaceutical compostition and its preparation method |
| 04/05/2006 | CN1754557A Chinese caterpillar fungus formulation preparation method |
| 04/05/2006 | CN1754550A Compound traditional Chinese medicine glossy ganoderma formulation and preparation method |
| 04/05/2006 | CN1754549A Chinese caterpillar fungus formulation preparation method |
| 04/05/2006 | CN1754548A Chinese caterpillar fungus injection preparation method |
| 04/05/2006 | CN1754540A Medicine containing general pasqueflower saponin composition and its preparation method and uses |
| 04/05/2006 | CN1754538A Methotrexate oral disintegrating tablet and its preparation method |
| 04/05/2006 | CN1754535A Paclitaxel analog microsphere for topical injection, its preparation method and uses |
| 04/05/2006 | CN1754533A Tamoxifen citrate oral disintegrating tablet and its preparation method |
| 04/05/2006 | CN1249243C Targetted liver cancer AFP gene siRNAs expression carrier and its constructing method and use |
| 04/05/2006 | CN1249088C Antitumour medicine containing recombinant bacterial toxin protein complex substance |
| 04/05/2006 | CN1249087C Novel human G-Protein coupled receptor |
| 04/05/2006 | CN1249082C Apoptosis promoting gene BNIPL, coding albumen and uses thereof |
| 04/05/2006 | CN1249076C Anti-tumour ginseng saponin aglycone derivatives |
| 04/05/2006 | CN1249062C Substituted imidazopyridines |
| 04/05/2006 | CN1249061C Sulfonamide and sulfamide substituted imidazoquinolines and its pharmaceutical composition and uses |
| 04/05/2006 | CN1249059C Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249033C Cyclic amp-specific phosphodiesterase inhibitors |
| 04/05/2006 | CN1248737C Vaccine containing saponin and sterol |
| 04/05/2006 | CN1248733C Tie2 receptor-induced gene transfer system for treating target tumor genes |
| 04/05/2006 | CN1248732C Embonate medicine composition containing bombesin-like product |
| 04/05/2006 | CN1248731C Combined application of tumor suppressor gene therapy and chemotherapy in preparation of pharmaceutical composition for treating tumor |
| 04/05/2006 | CN1248726C Pharmaceutical composition for treating cancer and its preparation method |
| 04/05/2006 | CN1248699C Method for preparing Chinese herb medicine freezing-drying power-injection for treating tumor |
| 04/05/2006 | CN1248688C Targeted freeze dried nanometer powder injection of hydroxycamptothecine bean phospholipid and its preparation method |
| 04/05/2006 | CN1248680C Injectable composition of paclitaxel |
| 04/04/2006 | US7022870 Antidepressants; sexual disorders; anticancer agnets; hormone replacement therapy |
| 04/04/2006 | US7022856 Carboline derivatives |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022846 Metabolites of prinomastat and their synthesis |
| 04/04/2006 | US7022832 Wherein secondary structure disintegrates upon attachment of the oligonucleotide to a target nucleic acid; anticarcenogenic agents, treatment of Ewing's sarcoma |
| 04/04/2006 | US7022819 Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof |
| 04/04/2006 | US7022818 of given amino acid sequence; use as a target for drug screening of antagonists or agonists of said receptor; receptor can bind persephin |
| 04/04/2006 | US7022730 Protein tyrosine phosphatases inhibitors |
| 04/04/2006 | US7022720 Synthetic diazonamides as novel anti-mitotic agents |
| 04/04/2006 | US7022717 Chemokine receptor binding heterocyclic compounds |
| 04/04/2006 | US7022715 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 04/04/2006 | US7022712 Acidification of drugs such as carbendazim, by mixing with buffers improving water solubility; anticarcinogenic agents |
| 04/04/2006 | US7022711 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones |
| 04/04/2006 | US7022706 Central nervous system disorders |
| 04/04/2006 | US7022704 5,6,7, 8-tetrahydro-imidazo-(1,2a)-pyrazine derivative; useful for treating restenosis and tumor |
| 04/04/2006 | US7022690 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 04/04/2006 | US7022500 Humanized immunoglobulins |
| 04/04/2006 | US7022482 Deactivation antigen protein; anticancer agents; Aids therapy |
| 04/04/2006 | US7022330 Dissolving epothilone analog such as ixabepilone in a mixture of tertiary-butanol in water to form a solution; drying solution; lyophilizing; drying in vacuum; packaging lyophilized product in a first vial and packaging second vial with nonionic surfactant |
| 04/04/2006 | US7022315 Administering a thiol-based chemoprotectant agent intra-arterially for therapy and prophylaxis of side effects of cytotoxic cancer therapy for tumors located in the brain, head or neck |
| 04/04/2006 | CA2379521C Methods to identify compounds that modulate rage |
| 04/04/2006 | CA2356544C Pyridotriazines and pyridopyridazines |
| 04/04/2006 | CA2262745C Highly lipophilic camptothecin derivatives |
| 04/04/2006 | CA2166315C Process for the preparation of thalidomide |
| 04/04/2006 | CA2120503C The regulation of systemic immune responses utilizing cytokines and antigens |
| 03/30/2006 | WO2006034234A1 Crystalline form 3 of atrasentan hydrochloride |
| 03/30/2006 | WO2006034113A2 Quinolone analogs as cell proliferation inhibitors |
| 03/30/2006 | WO2006034111A1 (arylamidoaryl)squaramide compounds |
| 03/30/2006 | WO2006034110A1 (arylamidoaryl) cyanoguanidine compounds as inhibitors of c-kit proto-oncogene |
| 03/30/2006 | WO2006034094A1 Crystalline form 1 of atrasentan hxdrochloride |
| 03/30/2006 | WO2006034085A1 Crystalline form of atrasentan hydrochloride |
| 03/30/2006 | WO2006034084A1 Crystalline form 2 of atrasentan hydrochloride |
| 03/30/2006 | WO2006034016A1 (arylamidoanilino) nitroethylene compounds |
| 03/30/2006 | WO2006034015A1 (spirocyclylamido) aminothiophene compounds as c-kit proto- oncogene inhibitors |
| 03/30/2006 | WO2006033913A2 Bis (thio-hydrazide amides) for treament of hyperplasia |
| 03/30/2006 | WO2006033796A1 SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AND PROCESS FOR MAKING SAME |
| 03/30/2006 | WO2006033795A2 Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth |
| 03/30/2006 | WO2006033631A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i |